Program
Thursday, 20 February 2025
| 12.00 | Registration |
| 13.00 | Welcome |
| 13.15 | Keynote The role of LTX in metabolic disease Carlo Dionisi-Vici (Rome) |
| 13.45 | Longterm outcome after LTX - Part 1 Post-LTX metabolism in MMA and other organic aciduria Diego Martinelli (Rome) Longterm outcome after LTX incl. quality of life Martina Sterneck, Louisa Lund (Hamburg) |
| 14.45 | Coffee Break | Industry Exhibition |
| 15.15 | Longterm outcome after LTX - Part 2 |
| Longterm cancer risk under immuno- suppression Wilhelm Wößmann (Hamburg) Transition in care: balancing between evidence and good care Anneloes van Staa (Rotterdam) |
|
| 16.15 | IPSEN Industry symposium Every baby deserves a genetic screening? Malin Fromme (Aachen) & Irina Hüning (Lübeck) |
| 16.45 | Hepatobiliary surgery & interventions Intraoperative bile duct imaging Ricardo Superina (Chicago) |
| 17.15 | End of the day |
| 19.00 | Congress dinner |
Friday, 21 February 2025
| 08.30 | Welcome |
| 08.45 | Keynote |
| Biliary atresia Claus Petersen (Hanover) |
|
| 09.15 | BARD Session on biliary atresia Podium discussion on when to go for transplantation Ricardo Superina (Chicago), Mark Davenport (London) |
| 10.00 | Coffee Break | Industry Exhibition |
| 10.30 | The hepatologists‘ view on biliary atresia Henkjan Verkade (Groningen) |
| 11.00 | 20 years national centralization of BA care Mikko Pakarinen (Helsinki) |
| 11.30 | MIRUM Industry symposium Unveiling the hidden signals: Biomarkers and symptoms in neonatal cholestasis André Hörning (Erlangen) & Thomas Kaiser (Münster) |
| 12.30 | Lunch Break | Industry Exhibition |
| 13.15 | Wilson‘s disease |
| New diagnostic tools and therapeutic innovation Isabelle Mohr (Heidelberg) |
|
| Pediatric acute liver failure in Wilson's Disease Piotr Socha (Warsaw) |
|
| 14.15 | Hepatology & genetics |
| Genetic markers and their prognostic significance in PFIC Henkjan Verkade (Groningen) |
|
| 14.45 | ERN activities and registries
ERN Rare Liver, ERN Transplant Child, MetabERN |
| 15.30 | Farewell |